Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Cognasse F, Hamzeh-Cognasse H, Duchez AC, Shurko N, Eyraud MA, Arthaud CA, Prier A, Heestermans M, Hequet O, Bonneaudeau B, Rochette-Eribon S, Teyssier F, Barlet-Excoffier V, Chavarin P, Legrand D, Richard P, Morel P, Mooney N, Tiberghien P.
Cognasse F, et al. Among authors: mooney n.
Front Immunol. 2022 Oct 7;13:1034379. doi: 10.3389/fimmu.2022.1034379. eCollection 2022.
Front Immunol. 2022.
PMID: 36275757
Free PMC article.